Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Josh Fry"'
Autor:
Vilim Dretar, Filip Radevski, Pavla Peraić, Josh Fry, Marko Belamarić, Marko Antunović, Ivan Krezić
Publikováno v:
Liječnički vjesnik
Volume 141
Issue suppl.1
Volume 141
Issue suppl.1
Hyperlipidaemia, hypercholesterolaemia and hypertriglyceridaemia are known as factors that increas blood pressure and risk of cardiovascular complications. We wanted to examine effects of pentadecapeptide BPC 157 on high-fat diet induced hypertension
Autor:
Ivan Krezić, Marko Antunović, Dominik Malekinušić, Emma Orešković, Pavla Peraić, Josh Fry, Marko Belamarić
Publikováno v:
Liječnički vjesnik
Volume 141
Issue suppl.1
Volume 141
Issue suppl.1
Pentadecapeptide BPC 157 demonstrates beneficial healing and anti-inflammatory effects on gastrointestinal and many extra - gastrointestinal tissues. Bile duct ligation causes inflammation and fibrotic changes in the liver. We wanted to explore effec
Autor:
Pavla Peraić, Dominik Malekinuić, Emma Orešković, Borna Vrdoljak, Filip Radevski, Josh Fry, Oliver Marcel Koltay
Publikováno v:
Liječnički vjesnik
Volume 141
Issue suppl.1
Volume 141
Issue suppl.1
Pentadecapeptide BPC 157 was previously shown as a cardioprotective compound in a model of arrhythmia induced by bupivacaine toxicity where it counteracts arrhythmias and prevents lethal outcome much like in other cardiotoxicity mainly related to pot
Autor:
Pavla Peraić, Josh Fry, Mariam Samara, Marko Belamarić, Marina Madunić, Hrvoje Vraneš, Zoya Jelovečki-Dokić
Publikováno v:
Liječnički vjesnik
Volume 141
Issue suppl.1
Volume 141
Issue suppl.1
BPC 157 (LD1 not achieved) was implemented as an anti-ulcer peptide in IBD trials and now in a multiple sclerosis trial. BPC 157 maintained corneal transparency, total debridement of corneal epithelium cured with no corneal neovascularization, perfor
Autor:
Vilim Dretar, Borna Vrdoljak, Emma Orešković, Oliver Marcel Koltay, Marko Antunović, Marina Madunić, Josh Fry
Publikováno v:
Liječnički vjesnik
Volume 141
Issue suppl.1
Volume 141
Issue suppl.1
We wanted to explore effect of pentadecapeptide BPC 157 therapy in temporary portal triad obstruction (PTO) (hepatic artery (HA), portal vein (PV), bile duct occlusion for 30 min in rats), and in reperfusion period in post-PTO-period on the counterac
Publikováno v:
Liječnički vjesnik
Volume 141
Issue suppl.1
Volume 141
Issue suppl.1
Pentadecapeptide BPC 157 is intraduced as therapy in a suprahepatic inferior caval vein (ICV) occlusion 15 min, 24h, 48h after complete ICV ligation. Suprahepatic ICV complications that were counteracted by BPC 157 included esophageal bleeding, sever
Autor:
Đurašin, Tajana, Jelovečki-Dokić, Zoya, Josh, Fry, Helena, Žižek, Pavla, Peraić, Filip, Radveski, Vrdoljak, Borna
Publikováno v:
Lijecnicki Vjesnik; 2019 Supplement, Vol. 141, p13-13, 1p